Inspire Medical Systems, Inc.
INSP
$162.16
$3.322.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 802.80M | 755.59M | 705.71M | 660.91M | 624.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 802.80M | 755.59M | 705.71M | 660.91M | 624.80M |
| Cost of Revenue | 122.99M | 115.05M | 107.04M | 101.45M | 96.58M |
| Gross Profit | 679.82M | 640.54M | 598.67M | 559.47M | 528.22M |
| SG&A Expenses | 529.61M | 512.20M | 495.06M | 475.59M | 451.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 766.72M | 742.10M | 720.00M | 696.90M | 665.07M |
| Operating Income | 36.08M | 13.50M | -14.29M | -35.99M | -40.27M |
| Income Before Tax | 58.45M | 37.06M | 8.53M | -14.05M | -19.91M |
| Income Tax Expenses | 4.94M | 4.01M | 2.52M | 1.68M | 1.25M |
| Earnings from Continuing Operations | 53.51 | 33.05 | 6.01 | -15.73 | -21.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 53.51M | 33.05M | 6.01M | -15.73M | -21.15M |
| EBIT | 36.08M | 13.50M | -14.29M | -35.99M | -40.27M |
| EBITDA | 42.63M | 18.39M | -10.48M | -32.90M | -37.43M |
| EPS Basic | 1.79 | 1.11 | 0.20 | -0.54 | -0.73 |
| Normalized Basic EPS | 1.22 | 0.78 | 0.18 | -0.30 | -0.43 |
| EPS Diluted | 1.72 | 1.07 | 0.18 | -0.55 | -0.74 |
| Normalized Diluted EPS | 1.18 | 0.76 | 0.17 | -0.31 | -0.44 |
| Average Basic Shares Outstanding | 119.05M | 118.74M | 118.23M | 117.73M | 117.20M |
| Average Diluted Shares Outstanding | 121.41M | 120.89M | 119.63M | 118.45M | 117.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
